Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

eClinical Solutions India Laxmi Bonagiri awarded Woman Icon of the Year Award

eClinical Solutions India

eClinical Solutions LLC, a leading provider of cloud-based enterprise software and software-driven clinical data services, is proud to announce Laxmi Bonagiri, Vice-President, eClinical Solutions India, was recently awarded the Woman Icon of the Year award at the Women Empowerment Summit and Great Indian Women Leader Awards (GIWL) 2019. Laxmi was also recognized as a Woman Leader of the Year. “I am deeply honored to be recognized by the GIWL Awards,” says Laxmi. “Promoting and empowering female leaders drives greater success and innovation across all sectors in every industry.

At eClinical Solutions, we value contributions from our entire team and understand that their insight and expertise are crucial elements in our ability to support clients in unlocking the power of their data.” Hosted by UBS Forums and held in Bengaluru on September 27, the event brought together experts and leaders across industries to provide direction, focus and clarity on topics that included how to empower women leaders, work-life balance and the importance of diversity.

Laxmi Bonagiri Vice President, India Operations Laxmi Bonagiri is an IIM Calcutta โ€“ IIT Madras alumna and technology leader with over 20 years of experience in Engineering, Operations and Project Management. She currently manages Indian operations for eClinical Solutions. Over the last 5 years, she has led a sustainable and highly effective delivery center in Bangalore which supports the organizationโ€™s competitiveness in the global markets.

Laxmi believes in developing processes that are simple, sustainable and measurable, and leads the team by example. Known for her multi-tasking skills, sheโ€™s focused on building the teamโ€™s culture around the same goals, placing emphasis on learning & development to enable the team to be multi-talented and highly productive. Previously, Laxmi served major Engineering Automation organizations at various levels for GE, ABB and Invensys. She worked as a Sr. Scientist in the field of Chemical Engineering for the Ministry of Science and Technology during the initial days of her career.

About eClinical Solutions LLC
eClinical Solutions is a leading provider of cloud-based enterprise software and software-driven clinical data services. The elluminateยฎ platform provides life sciences companies with greater control of their clinical trial data. elluminate software and data driven services have been used by more than 80 life sciences companies on more than 400 trials.ย For more information, visitย http://www.eclinicalsol.com

RAPIDPoint 500e Blood Gas System from Siemens Healthineers featuring Integri-sense Technology

Siemens Healthineers featuring Integri-sense Technology

Siemens Healthineers announced the new RAPIDPoint 500e Blood Gas System, the latest solution in critical point-of-care testing. The new system generates blood gas, electrolyte and metabolyte results used to diagnose and monitor critically ill patients typically in the intensive care unit, operating room or emergency room. The RAPIDPoint 500e Blood Gas System is available now in all countries requiring the CE mark.

Developed with extensive customer feedback, the RAPIDPoint 500e system is designed to elevate confidence in patient results with Integri-sense Technology, streamline workflow with improved simplicity and raise the bar in data security.

โ€œClinicians need an intuitive blood gas testing solution that provides accurate results in a secure environmentโ€ said Dr. Christoph Pedain, Head of Point of Care Diagnostics, Siemens Healthineers. โ€œIn addition, cybersecurity is becoming a key operational factor. Healthcare providers must protect confidential operator and patient information.โ€

โ€œAs an ICU physician, I know that the values I am handed during an emergency allow me to confidently make life-saving decisions. The RAPIDPoint system is easy to use and allows me to not worry about the machine and focus my attention on my patients,โ€ said Dr. Daniel Martin, Royal Free Hospital, London.

The RAPIDPoint 500e system also integrates seamlessly into hospital networks with the Siemens Healthineers Point of Care Ecosystemโ„ข which offers convenient, remote management of operators and devices located across multiple sites.

Siemens Healthineers enables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services. In fiscal 2018, which ended on September 30, 2018, Siemens Healthineers generated revenue of โ‚ฌ13.4 billion and adjusted profit of โ‚ฌ2.3 billion and has about 50,000 employees worldwide.

Texas Surgical Hospital Taps Benefits of Carestream Diagnostic Imaging Technology

Texas Surgical Hospital Taps Benefits of Carestream Diagnostic Imaging Technology

Physician-owned South Texas Surgical Hospital has improved user workflow and created efficiencies across its facility with the use of Carestreamโ€™s DRX-Revolution Mobile X-ray System and a CARESTREAM DRX-1 System, both using DRX-Plus detectors.

โ€œWeโ€™re a surgical hospital so weโ€™re primarily here to provide service to the operating room. We do have an in-patient unit and a small emergency room,โ€ said Lisa Mason, Radiology Manager at South Texas Surgical Hospital. โ€œThe mobile DRX-Revolution has been invaluable in being able to go into the operating room during total hip replacement surgeries, where the surgeon doesnโ€™t want a C-arm in there the entire time. He just needs us to come in and take a couple of quick pictures during the procedure so he can see them in real time on the screen and then weโ€™re out.โ€

โ€œWith the DRX-Revolution, itโ€™s a quick in and out and it serves the same purpose as a C-arm. The surgeons all love it,โ€ Ms. Mason added.

The CARESTREAM DRX-Revolution Mobile X-ray System provides fast, convenient digital radiography imaging for patients at the bedside, in the operating room, the intensive care unit or the emergency room. The portable system eliminates blind navigation in hallways, elevators and patient rooms, offering unparalleled maneuverability in tight spaces. At South Texas Surgical Hospital, the unit is housed in the radiology department and used throughout the hospital.

โ€œWe were looking online at the portables, we were watching videos to see how they work. The thing that stuck with me is that Carestream acquired input from technologists in designing it,โ€ Ms. Mason said. โ€œWho better to say how an X-ray unit should operate than the ones who use it all day? Thatโ€™s what made me want to get in contact with Carestream and see what the system does.โ€

South Texas Surgical Hospital also used Carestreamโ€™s DRX-1 System to retrofit an existing analog X-ray room. The wireless DRX-Plus detector slides into existing X-ray equipment and can be used with imaging systems throughout a facility. South Texas Surgical uses the DRX detector in their retrofitted room where they perform chest exams.

โ€œWe purchased a larger detector, the 17 x 17, which is great for us because weโ€™re imaging chests all day,โ€ Ms. Mason explained. โ€œSo we never have to take it out and turn it around to get the horizontal and vertical orientations. We just leave it in there. It saves us time.โ€

Carestreamโ€™s DRX detectors, which lie at the core of its DRX portfolio, feature wireless connectivity to eliminate the hassles and hazards of cables and reduce the risk of infection; deliver instant access to images to speed decisions on patient care; and provide the ability to share detectors between any DRX room or any mobile DRX system. It also has a separate battery charger that allows the detector to be used while a spare battery is being charged.

Carestreamโ€™s guidance as South Texas Surgical Hospital made its purchasing decision, especially on the DRX-Revolution system, helped make the process easy. โ€œFrom the first phone call, everybody was so helpful in getting us the information we needed,โ€ Ms. Mason said.

FDA Clears AiCE Image Reconstruction on Canon Aquilion Precision CT

FDA Clears AiCE Image Reconstruction on Canon Aquilion Precision CT

Canon Medical Systems USA, Inc. has received 510(k) clearance on its Advanced Intelligent Clear-IQ Engine (AiCE) for the Aquilion Precision further expanding access to its new deep convolutional neural network (DCNN) image reconstruction technology. This technology, now available on both the Aquilion Precision and Aquilion ONE / GENESIS EditionTM premium CT systems, uses a deep learning algorithm to differentiate signal from noise so that it can suppress noise while enhancing signal, forging a new frontier for CT image reconstruction.

Aquilion Precision โ€“ the worldโ€™s first Ultra-High Resolution CT provides 2 times the resolution of conventional CT, revealing detail that is typically only seen in Cath labs. With AiCE, the system now enables clinicians to perform super-high resolution studies at doses equivalent to standard resolution CT (with traditional hybrid iterative reconstruction techniques). AiCE learns from the high image quality of Model Based Iterative Reconstruction (MBIR) to reconstruct CT images with improved high contrast spatial resolution*.

โ€œAs we strive for precision medicine, we realize the importance of starting with the foundation of a precise diagnosis. Canon Medical is committed to developing intelligent solutions that help providers generate clearer, more holistic images to help achieve better outcomes, without increasing dose,โ€ said Tim Nicholson, acting managing director, CT Business Unit, Canon Medical Systems USA. โ€œThis technology represents a new era in image reconstruction, which may help provide more possibilities in improving patient care than ever before.โ€

About Canon Medical Systems USA, Inc.

Canon Medical Systems USA, Inc., headquartered in Tustin, Calif., markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and interventional X-ray equipment. For more information, visit Canon Medical Systemsโ€™ website at https://us.medical.canon.

About Canon Medical Systems Corporation

Canon Medical offers a full range of diagnostic medical imaging solutions including CT, X-Ray, Ultrasound and MR, across the globe. In line with our continued Made for Life philosophy, patients are at the heart of everything we do. Our mission is to provide medical professionals with solutions that support their efforts in contributing to the health and wellbeing of patients worldwide. Our goal is to deliver optimum health opportunities for patients through uncompromised performance, comfort and safety features.

At Canon Medical, we work hand in hand with our partners โ€“ our medical, academic and research community. We build relationships based on transparency, trust and respect. Together as one, we strive to create industry-leading solutions that deliver an enriched quality of life. For more information, visit the Canon Medical website: https://global.medical.canon

LPIXEL Launch of Japan’s first Deep Learning-Powered SaMD for Brain MRI, EIRL aneurysm

LPIXEL Launch of Japan's first Deep Learning-Powered SaMD for Brain MRI, EIRL aneurysm

LPIXEL Inc., a leader in image analysis and processing in life science and medical research, announced the approval of โ€œEIRL aneurysm,โ€ its image analysis software that uses deep learning to identify suspected aneurysms from brain MRI. EIRL aneurysm is the first deep learning-powered software as a medical device (SaMD) for brain MRI to receive approval from the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan.

The PMDA is the agency responsible for regulating and approving pharmaceuticals and medical devices in Japan. LPIXEL successfully secured approval on September 17, 2019, and will make EIRL aneurysm commercially available in Japan.

EIRL aneurysm Overview
Product Name: Medical Image Analysis Software โ€œEIRL aneurysmโ€
Certification Number: 30100BZX00142000

Major Features
1. Image Interpretation Support
EIRL aneurysm supports the interpretation process by identifying sac-like structures of aneurysms in brain MRI that are larger than 2 mm. The sensitivity of the doctor interpreting the images without the software was 68.2%. In comparison, the sensitivity with the assistance of the software was 77.2%, suggesting an improvement in diagnostic accuracy. [1]

[1] The average interpretation results of 20 radiologists for 50 cases that included unruptured aneurysms and 150 normal cases that did not contain aneurysms.
ใƒป5 radiologists with less than 5 years of experience, and 5 radiologists with more than 5 years of experience.
ใƒป6 neurosurgeons with less than 6 years of experience and 4 with more than 6 years of experience.

2. Seamless Integration with PACS and Modalities
With its compatibility with DICOM, which is the universal format for image storage and transfer, image data can be sent and received with the pre-existing PACS and modalities installed in the hospital system. This seamless workflow allows for the analysis results to be delivered straight to the radiologistโ€™s workstation.

The Widespread of Brain Screening in Japan
With Japan leading the world with the largest number of MRI scanners in the world [2] , patients are able to take a โ€œbrain dock,โ€ or an in-depth medical examination of the brain, at a reasonable cost. Oftentimes, aneurysms are discovered during this examination. If the aneurysm ruptures, blood will bleed into the space of the brain, causing subarachnoid hemorrhage (SAH).

[2] Based on an investigation conducted by OECD in 2017, Japan has 51.7 MRI units per million population, which is significantly higher compared to the average number of units in the G7 and OECD member countries, listed at 25.8 units and 15.2 units, respectively.

Reducing Radiologist Workload
The rapid growth of medical image data caused by the advent of imaging modalities, such as MRI, has been strongly tied to the increased workload for radiologists and neurosurgeons. There is a pressing need to promote workplace reforms in the medical space, and using technological advances to provide efficient, high quality medical care is being strongly encouraged.

About EIRL
EIRL is the collective name given to LPIXELโ€™s AI medical image diagnostic support technology. LPIXEL aims to provide solutions that enable a faster and more accurate diagnosis by implementing its unique algorithms to analyze medical big data, such as brain and breast MRI, chest X-rays, and colonoscopy.

About LPIXEL
LPIXEL is a leader in advanced image analysis and processing technology encompassing the life science field. Founded in March 2014, LPIXEL is dedicated to offering research facilities top-tier image analysis technologies and medical diagnosis technologies, both of which adopt advanced AI technology. The company is currently working in collaboration with the University of Tokyo Hospital, the National Cancer Center Japan and other research institutions to further the development of its AI-based medical diagnosis technology. For more information, please visit https://lpixel.net/en/

Elekta wins the Technology Services Industry Association STAR award

Elekta wins the Technology Services Industry Association STAR award

The Technology Services Industry Association (TSIA) has presented Elekta (EKTA-B.ST) with its STAR award โ€“ a great honor in the technology services industry. The award recognizes commitment to outstanding innovation, leadership and excellence, and highlights best practices across industries. With this accolade, the TSIA acknowledges Elekta as an industry leader in Field Service.

Richard Hausmann, President and CEO, Elekta, said: โ€œWe are honored to win the 2019 STAR Award Best Practices in Field Service. With millions of people around the world facing cancer every year, we know that every treatment counts. Being a service organization in the healthcare industry today is about helping customers be more efficient in how they deliver patient care which requires more than onsite support.โ€

Paul Bergstrรถm, Executive Vice President, Global Service, Elekta added: โ€œReceiving this STAR award recognizes the innovation, as well as dedication and commitment, from our on-site Elekta service engineers, support agents and technicians that cater for round-the-clock support, which is vital for customers. Our service transformation initiatives are ongoing and successfully being implemented โ€“ maximizing clinical availability, helping to advance precision radiation medicine, minimizing costs and most importantly โ€“ reducing the chance of disruption to patients.โ€

Elektaโ€™s predictive maintenance solution, powered by Elekta IntelliMaxยฎ, is one of the drivers for the recognition. In four months alone, 6,316 hours of downtime have been avoided due to the systemโ€™s predictive maintenance capabilities. Instead of waiting for a machine failure, IntelliMax alerts the service organization to possible issues that can be addressed beforehand. Avoiding downtime with predictive maintenance during this period meant that 18,000 patients could have their treatments as scheduled without all the negative impact that rescheduling might have. Elekta continues to invest in solutions that solves problems before they happen.

Mr. Bergstrรถm added: โ€œAs the need for cancer treatment continues to increase, so will the need for us to help our customers be productive and deliver treatments according to their patientโ€™s treatment schedule. We will continue our work to ensure that every patient receives the care they need.โ€

About Elekta
For almost five decades, Elekta has been a leader in precision radiation medicine. Our nearly 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to โ€“ and benefits from โ€“ more precise, personalized radiotherapy treatments.

The Technology Services Industry Association (TSIA)
The Technology Services Industry Association (TSIA) is the world’s leading organization dedicated to advancing the business of technology and services. Technology services organizations large and small look to TSIA for world-class business frameworks, best practices based on real-world results, detailed performance benchmarking, exceptional peer networking opportunities, and high-profile certification and awards programs. TSIA corporate members represent the world’s top technology companies as well as scores of innovative small and mid-size businesses in four major markets: enterprise IT and telecom, consumer technology, healthcare and healthcare IT, and industrial equipment and technology.

Continental Hospitals partners with cyberabad police, SCSC and Lions club to make Hyderabad emergency ready

Continental Hospitals partners with cyberabad police, SCSC and Lions club to make Hyderabad emergency ready

Continental Hospitals celebrated of new life by felicitating the heroes that work to give another life to the trauma victims โ€“ the Ambulance drivers. This was a part of a series of awareness programs organized by the Hospital in partnership with the Cyberabad Police, SCSC and Lions club to make Hyderabad emergency ready.

The Chief Guest for the event was Shri. S M Vijay Kumar, IPS – DCP Traffic, Cyberabad and Convener, Traffic Safety Forum, SCSC and the guest of honor was Mr. Krishna Yedula, Gen. Secretary SCSC. The event was also graced by the presence of Lion Saurabh Sureka, Social Entrepreneur and Charter President โ€“ Lions Club of Hyderabad YUVA. The event saw some heart touching shares by both the ambulance drivers and the victims.

With one trauma-related death occurring in India every 1.9 minutes, deaths due to trauma exceeded those due to cancer and heart diseases combined in India. In this regard, Continental Hospitals have taken up โ€“ Making Hyderabad emergency ready as its mission. The hospital is conducting various awareness programs as part of this endeavor.

A society is empowered when the individuals in the society are empowered. To make Hyderabad Emergency ready, the hospital have already started basic life support programs in various communities and corporates. The hospitals aims to create First Aid champions in these communities. It is extremely important for individuals to be trained as a basic support by the bystander can increase the chances of survival of the victim.

About Trauma Care at Continental
The Continental Institute of Emergency, Trauma Services & Critical Care Management is a Level 1 Tertiary comprehensive center equipped to deal with every type of urgent life threatening condition. We are of the select few private hospitals in Hyderabad and South India to have a bedded A&E equipped with state-of-the-art equipment for a wide spectrum of patients with acute emergencies for initial evaluation, resuscitation, treatment, investigation, stabilization, monitoring and disposition. Working round the clock, our physicians have access to highly advanced and accurate laboratory and radiology tests. Our Continental Life Care on Wheels Ambulance Service has an efficient and high tech line of ambulances that are available 24*7 to transport critically ill or injured patients.

The salient features of the trauma unit of Continental hospital are:

  1. More than 97% success rate in treating road accidents
  2. Operates mobile ICUs which reduces the risk of mortality while transfer
  3. 24×7 ER consultants on premises backed by experts in allied super specialties
  4. Follows international standards of trauma care
  5. Easy assessable with close proximity to Outer Ring Road

About Continental Hospitals, Hyderabad
Continental Hospital is a NABH and JCI-accredited facility in Hyderabad offering multi-specialty tertiary and quaternary care services. The hospital has a capacity of 750 beds with 250 operational beds currently. The hospital has Green OT, Level 3 NICU and PICU, and itโ€™s known for efficient critical care team. The hospital has state-of-the-art facilities and medical equipment, as well as the latest communication and information technology. Key specialties include Cardiac Sciences, Neuro Sciences, Gastroenterology, Obstetrics and Gynaecology, Oncology, Orthopaedics and Emergency Medicine.

Continental Hospitals is a part of IHH Healthcare, a leading premium integrated healthcare provider with a network of 84 hospitals and more than 16,000 licensed beds. It is one of the largest healthcare groups in the world by market capitalisation and is listed in the Main Market of Bursa Malaysia and Main Board of SGX-ST. IHH is a leading player in the home markets of Malaysia, Singapore, Turkey and India, and in their key growth markets of China and Hong Kong.

Synaptive Presents Key Features of Its Modus V Robotic Surgical Microscopy at the 2019 CNS Annual Meeting

 Synaptive Presents Key Features of Its Modus V Robotic Surgical Microscopy at the 2019 CNS Annual Meeting

Synaptive Medical, a leader in automation and robotics, will deliver two presentations showcasing the capabilities of Modus V, Synaptiveโ€™s robotically controlled digital microscope designed for use in cranial and spinal procedures, during the 2019 Congress of Neurological Surgeons (CNS) Annual Meeting.

Modus Vโ€™s robotic arm moves automatically based on the positions of tracked surgical instruments. This empowers surgeons to operate continuously without removing their hands from the operative field to adjust the microscope. Along with other optical features such as automatic lighting adjustments and hands-free focal depth control, these hands-free capabilities offer surgeons informative and ergonomically friendly perspectives throughout delicate surgical procedures.

In a live 3D streaming event on Monday, October 21 at 10 a.m. PDT, titled, โ€œLive Tumor Surgery in 3D using Synaptiveโ€™s Robotic Digital Microscope,โ€ Dr. Costas Hadjipanayis will perform a live surgical procedure using Synaptiveโ€™s Modus V, as well as Synaptiveโ€™s Modus Planโ„ข automated tractography software, while Dr. Brian Nahed will moderate the surgery on site at CNS. The surgery will take place at The Mount Sinai Hospital in New York City and broadcasted in the CNS meetingโ€™s Xperience Lounge on the Exhibit Hall Floor.

On Tuesday, October 22, at 9:50 a.m. PDT in Synaptiveโ€™s booth (318), Dr. Hadjipanayis will deliver a surgical presentation featuring novel features of the robotic digital microscope.

A respected surgical neuro-oncologist, Dr. Hadjipanayis is a Professor of Neurosurgery and Oncological Sciences at Icahn School of Medicine at Mount Sinai Site Chair, Department of Neurosurgery at Mount Sinai Union Square Director, Neurosurgical Oncology at Mount Sinai Health System Director, Brain Tumor Nanotechnology Laboratory.

โ€œThe tangible benefits of using Modus V have been clinically validated via multiple peer-reviewed publications but are most compelling when communicated visually in a surgical setting,โ€ said Cameron Piron, president and chief strategy officer of Synaptive. โ€œWeโ€™re grateful for this opportunity at CNS to show what the sum of this microscopeโ€™s features can accomplish in the hands of someone like Dr. Hadjipanayis, in terms of navigating patient-specific neuroanatomy while avoiding delicate brain structures that, if disrupted, could cause serious harm to the patient.โ€

Synaptiveโ€™s Modus V and Modus Plan products are part of the companyโ€™s suite of automated, integrated hardware and software offerings designed to extend healthcare providersโ€™ abilities to offer safe, patient-specific neurological and orthopedic care.

About Synaptive Medical

Synaptive Medical Inc., a Toronto-based medical device and technology company, designs hardware and software technologies that cross traditional barriers in hospitals and improve patient care in and beyond the operating room. Synaptiveโ€™s Modus Vโ„ข and integrated BrightMatterโ„ข solutionsโ€”including surgical planning, navigation and visualization, and an informatics platformโ€”give leading clinicians and healthcare systems the information they need to ensure the best possible outcomes for patients.

Europe Immunohematology Market Size to Exceed USD 442 Mn By 2024

Europe Immunohematology Market Size to Exceed USD 442 Mn By 2024

According to the Graphical Research new growth forecast report titled โ€œEurope Immunohematology Market By Product (Analyzers, Reagents), By Technology (Biochips, Gel Cards, Microplates, PCR, Erythrocyte-magnetized Technology), By End-use (Hospitals, Diagnostic Laboratories, Blood Banks) Industry Analysis Report, Regional Outlook (Germany, UK, France, Spain, Italy, Russia, Poland, Czech Republic, Hungary, Switzerland, Denmark, Ireland, Netherlands, Bulgaria, Sweden, Austria), End-use Potential, Competitive Market Share & Forecast, 2018 โ€“ 2024โ€, exceed to exceed USD 442 million by 2024.

Rising prevalence of hematology disorders in European countries will foster industry growth. A stupendous rise in prevalence of hematological disorders including sickle-cell, leukemia and thalassemia is a major contributing factor driving demand for immunohematology analyzers. Thalassemia is an inherited blood disorder that results in an inadequate amount of hemoglobin production. The disorder results in destruction of large number of red blood cells causing anemia. Such patients need recurrent blood transfusions that proves beneficial for the industry growth.

Technological advancements in immunohematology analyzers is projected to drive the industry growth throughout the analysis period. Increasing focus of industry players on developing advanced immunohematology technologies will elevate the demand for immunohematology devices. For instance, several companies have launched a fully automated and high-throughput system for immunohematology. Advanced immunohematology systems can be used in

grouping, antibody screening, phenotyping, donor antibody screening, identification and cross-matching. Availability of such technologically advanced products will stimulate the industry growth. However, stringent regulatory scenario for immunohematology devices may hamper the business growth to some extent.Reagents segment held more than 65% revenue share in 2017 and will witness lucrative CAGR by 2024. This significant growth can be attributed to increasing number of haematological disorders that will surge the need for recurring blood testing. Additionally, diagnostic centres prefer reagents that provide results with high specificity. ย Above mentioned factors will escalate the segmental growth.

Microplates segment was valued around USD 60 million in 2017 and is projected to show similar growth during the forecast period. Significant segmental growth can be attributed to advancements in microplates. Technologically upgraded microplates provide several advantages including cost-effectiveness, reusability, easy and rapid washings for antiglobulin tests. Furthermore, microplate testing is reliable with relatively small amount of reagents as compared to tube testing and thus, its adoption will increase in the coming years.

Blood banks segment accounted for substantial revenue in 2017 and will experience 1.7% growth over the analysis timeframe. Blood banks are gaining traction and have the potential to escalate sales of immunohematology devices as number of blood transfusions is increasing annually. Growing awareness regarding blood donation and increase in the number of voluntary donors will render significant impact on the business growth.

Few major industry players include Abbott, ANTISEL S.A., Beckman Coulter, Becton Dickinson, Bio-Rad Laboratories, Diagast, Grifols, Hologic, Immucor, Roche Diagnostics, Siemens Healthcare and Thermo Fisher Scientific. These key industry players adopt several strategic initiatives to enhance their revenue share. Approvals for new products will also prove beneficial for the industry growth. For instance, In October 2016, Immucor announced that its U.S. FDA approval for PreciseType HEA test to screen Sickle Cell Trait. The test provides clinicians and blood banks with the complete genetic matching information they need to reduce the risk of alloimmunization. The move will help to expand companyโ€™s existing product line.

South Beach Symposium hosts renowned faculty, interactive learning

South Beach Symposium hosts renowned faculty, interactive learning

South Beach Symposium is gearing up for the upcoming 18th Annual South Beach Symposium taking place in Miami Beach, FL from February 6-9, 2020.

The annual conference boasts an extensive agenda, with in-depth pre-conference offerings, and sessions topics covering the latest and most well-supported knowledge in clinical and aesthetic dermatology. Rooted in an outcomes-focused approach to dermatology treatment, South Beach Symposium stands apart as a principal force in a revolutionary shift towards patient-centered dermatology care.

The event will start off with two advanced CME/CE one-day pre-conference sessions on February 6th, highlighting two of the industryโ€™s most pressing and in-demand areas. The Masters of Pediatric Dermatology Symposium will center around the latest treatment approaches, protocols, procedures, and tools needed to support children with dermatologic conditions. With up to 6 CME/CE credits available, this symposium is designed to help practitioners to ultimately provide better, more personalized care for a younger population of patients. The Cutaneous Oncology Symposium will serve to bridge the gap between advanced dermatology and oncology care in patients with skin cancer. Provided in partnership with the American Cutaneous Oncology Society, this new pre-conference offering will take an in-depth look into the latest advancements and clinical research surrounding advanced skin cancer diagnosis, treatment, and management.

The conference boasts a renowned faculty line-up consisting of the industryโ€™s leading authorities, including George Hruza, MD, MBA, FAA, the current president of the American Academy of Dermatology, Diane Berson, MD the past President, Womenโ€™s Dermatologic Society, Neal Bhatia, MD, the incoming Vice President-Elect of the American Academy of Dermatology, and much more.

Designed to serve as an actionable aid for dermatology practitioners, the 18th Annual South Beach Symposium will deliver valuable insider knowledge through a variety of educational formats including interactive Q&A sessions, didactic lectures, live demonstrations, and more. Created, developed, and led by a leading industry experts, session topics will cover the most relevant topics in clinical and aesthetic dermatology including clinical procedural complications, treatment updates in hair restoration, devices and treatments in aesthetics, innovations in clinical therapeutics, atopic dermatitis, the spectrum of eczema, and much more”

Translate ยป